Narcolepsy

February 25, 2015

Background According to the Narcolepsy Network, although it affects more than 200,000 people in the US, narcolepsy is estimated to be undiagnosed or untreated in 75% of people with the disorder. This lack of recognition leads to delays in effective treatment and decreased quality of life....

January 28, 2015

In Diagnosis, Idiopathic Hypersomnia, Journal Article Summaries, Narcolepsy

By Hypersomnia Foundation

Can Actigraphy Help to Differentiate People with Narcolepsy from People with Idiopathic Hypersomnia?

Why is this study important? Type 1 narcolepsy (T1N) and idiopathic hypersomnia (IH) are both disorders of central hypersomnolence. Even though the International Classification of Sleep Disorders, third edition, includes a finding of 11 hours of sleep during a 24-hour period (as measured by actigraphy for at least 7...

December 3, 2013

In All Hypersomnias, Clarithromycin, Idiopathic Hypersomnia, Journal Article Summaries, Kleine-Levin Syndrome, Narcolepsy, Other Hypersomnias

By Hypersomnia Foundation

Summary of Research into Clarithromycin as a Hypersomnia Treatment

GABA is known to promote sleep and decreased consciousness, and many patients with CNS hypersomnia have been found to have endogenous GABA-A receptor hyper-reactivity. Flumazenil, a known GABA-A antagonist, has been shown to reduce symptoms in these patients, but its use may be impractical; therefore,...

How Long Does It Take for Sodium Oxybate to Work?

Can Actigraphy Help to Differentiate People with Narcolepsy from People with Idiopathic Hypersomnia?

Summary of Research into Clarithromycin as a Hypersomnia Treatment

Get SomnusNooze, our e-newsletter

Donate

Follow Us

Contact Us